In the BioHarmony Drug Report Database
Arsenic trioxide
Trisenox (arsenic trioxide) is a small molecule pharmaceutical. Arsenic trioxide was first approved as Trisenox on 2000-09-25. It is used to treat promyelocytic leukemia acute in the USA. It has been approved in Europe to treat promyelocytic leukemia acute.
Trade Name
|
Trisenox |
|---|---|
Common Name
|
arsenic trioxide |
ChEMBL ID
|
CHEMBL2362016 |
Indication
|
promyelocytic leukemia acute |
Drug Class
|
Antineoplastic agent |
Image (chem structure or protein)